Form 4 for IDXX Idexx Laboratories
Accepted 2025-08-08 00:00:00 ET · period of report 2025-08-06 · accession 0000874716-25-000127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-08-08 | 2025-08-06 | IDXX | Hunt Nimrata | EVP | M - OptEx | $187.57 | +12.8K | 25.1K | +104% | +$2.40M |
| DM | 2025-08-08 | 2025-08-06 | IDXX | Hunt Nimrata | EVP | S - Sale+OE | $630.43 | -7,143 | 22.1K | -24% | -$4.50M |
| DM | 2025-08-08 | 2025-08-06 | IDXX | Hunt Nimrata | EVP | M - OptEx | $0.00 | -12.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-06 | M | A | 5,865 | $178.26 | 19,438.94 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-06 | S | D | 1,218 | $630.69 | 18,006.94 | D | — | — | |
| 3 | Common | Common Stock | 2025-08-06 | S | D | 2,907 | $630.91 | 19,224.94 | D | — | — | (F2) Represents the weighted average price of the shares sold ranging from a low of $630.50 to a high of $630.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 4 | Common | Common Stock | 2025-08-06 | S | D | 3,018 | $629.87 | 22,131.94 | D | — | — | |
| 5 | Common | Common Stock | 2025-08-06 | M | A | 1,218 | $141.60 | 13,573.94 | D | — | — | (F1) Includes a total of 28.7090 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025. |
| 6 | Common | Common Stock | 2025-08-06 | M | A | 5,711 | $206.94 | 25,149.94 | D | — | — | |
| 7 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2025-08-06 | M | D | 5,865 | $0.00 | 0 | D | $178.26 · — to 2028-02-13 | 5,865 Common Stock | (F4) Grant of option to buy shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2019. |
| 8 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2025-08-06 | M | D | 1,218 | $0.00 | 0 | D | $141.60 · — to 2027-02-13 | 1,218 Common Stock | (F3) Grant of option to buy shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2018. |
| 9 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2025-08-06 | M | D | 5,711 | $0.00 | 0 | D | $206.94 · — to 2029-02-13 | 5,711 Common Stock | (F5) Grant of option to buy shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2020. |